3.1. Participants
A total of 187 women were enrolled in the trial, of which 101 were randomized: 50 were assigned to the MED-01-intake group and 51 to the placebo-intake group (However, seven and nine subjects meeting the exclusion criteria were excluded from the MED-01 and placebo groups in the FA set, respectively. Thus, the efficacy of MED-01 was finally evaluated in 39 and 37 subjects in the MED-01 and placebo groups, respectively, without significant violations affecting the test results (PP set, 